Transcript segment

Baric Transcribed Interview (Redacted), p.19 · baric_ti:utt:00094

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Christina Salazar
Topics: Therapeutics and treatments

And it sounds like, the notes that I have -- and again, if you don't recall this, just let me know -- it appears that you may have mentioned that you had some confidentiality issue with remdesivir, within Nature Communications.

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
And it sounds like, the notes that I have -- and again, if you don't recall this, just let me know -- it appears that you may have mentioned that you had some confidentiality issue with remdesivir, within Nature Communications.	needs context	uncertain explicit hedge	asserts

Statement

Grade

Attribution

Stance

needs context

uncertain explicit hedge

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Christina Salazar open

And so I have a little bit of information that might refresh your recollection. You just tell me if this sounds familiar. So Peter Daszak was also on the call. Does that refresh your --
2026-04-10 09:00 Ralph S. Baric open

Not with the Chinese.
2026-04-10 09:00 Christina Salazar open

Not with the Chinese. With Eric Stemmy.
2026-04-10 09:00 Ralph S. Baric open

Oh, he may have been. Yes, he may have DC.Scheduling@LexitasLegal.com been.
2026-04-10 09:00 Christina Salazar

And it sounds like, the notes that I have -- and again, if you don't recall this, just let me know -- it appears that you may have mentioned that you had some confidentiality issue with remdesivir, within Nature Communications.
2026-04-10 09:00 Ralph S. Baric open

Yeah.
2026-04-10 09:00 Christina Salazar open

Okay. And that you were willing to share what you knew with leadership at NIH, but that you couldn't share it. You had to have some kind of assurance that it wouldn't be shared more broadly.
2026-04-10 09:00 Ralph S. Baric open

I don't recall this, but he may have been wanting a copy of the paper that I just mentioned. I may have sent it to them. I don't see why I wouldn't. The big question would be whether Gilead would have a problem, not that I would have a problem with it.
2026-04-10 09:00 Christina Salazar open

So what's the confidentiality agreement when you're --

Full conversation →